 MELBOURNE, Australia, Feb. 17, 2021 GLOBE NEWSWIRE -- Opthea Limited ASX:OPT, Nasdaq: OPT, a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, today announced that Dr Megan Baldwin, CEO of Opthea, will virtually present and provide a corporate update at the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021 at 3:40pm ET Thursday, February 25, 2021 at 7:40am AEDT. 